Pathology
Main Filters
Pathology
| LEICA BIOSYSTEMS NEWCASTLE LTD | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| NCL-L-PSMA | 0 | - | ||
| NCL-L-VEGFR3 | 0 | - | ||
| NCL-L-VILLIN | 0 | - | ||
| RE7101 | 0 | - | ||
| RE7102 | 0 | - | ||
| RE7107 | 0 | - | ||
| RE7113 | 0 | - | ||
| RE7116 | 0 | - | ||
| RE7119 | 0 | - | ||
| RE7133 | 0 | - | ||
| RE7160-K | 0 | - | ||
| SHANDON DIAGNOSTICS LIMITED | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| HM325 ROTARY MICROTOME E | 0 | - | ||
| NX50 CRYOSTAR OP | 0 | - | ||
| NX50 CRYOSTAR OP 220-230V | 0 | - | ||
| NX50 CRYOSTAR OPH | 0 | - | ||
| NX50 CRYOSTAR OPH | 0 | - | ||
| NX50 CRYOSTAR OPH | 0 | - | ||
| NX50 CRYOSTAR OPHD | 0 | - | ||
| NX50 CRYOSTAR OPHV | 0 | - | ||
| NX50 CRYOSTAR OPHV | 0 | - | ||
| NX50 CRYOSTAR OPHVD | 0 | - | ||
| NX50 CRYOSTAR OPV | 0 | - | ||
| NX50 CRYOSTAR OPV | 0 | - | ||
| NX70 CRYOSTAR 100V | 0 | - | ||
| NX70 CRYOSTAR 110-120V | 0 | - | ||
| NX70 CRYOSTAR 220-230V | 0 | - | ||
| NX70 CRYOSTAR WITH | 0 | - | ||
| NX70 CRYOSTAR WITH | 0 | - | ||
| NX70 CRYOSTAR WITH | 0 | - | ||
| NX70 CRYOSTAR WITH COLD D | 0 | - | ||
| NX70 CRYOSTAR WITH COLD D | 0 | - | ||
| NX70 CRYOSTAR WITH COLD D | 0 | - | ||
| NX70 CRYOSTAR WITH COLD D | 0 | - | ||
| NX70 CRYOSTAR WITH COLD D | 0 | - | ||
| NX70 CRYOSTAR WITH COLD D | 0 | - | ||
| THE BINDING SITE GROUP LIMITED | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| EA068.A | 0 | - | ||
| EA069.A | 0 | - | ||
| EA070.A | 0 | - | ||
| EA114.A | 0 | - | ||
| EA115.A | 0 | - | ||
| EA116.A | 0 | - | ||
| EA116.L.A | 0 | - | ||
| EA118.A | 0 | - | ||
| LK022.A | 0 | - | ||
| MA004 | 0 | - | ||
| MA010 | 0 | - | ||
| MA012 | 0 | - | ||
| MA015 | 0 | - | ||
| MA017 | 0 | - | ||
| NB136 | 0 | - | ||
18,175 Results
Results Per Page
- 50
- 100
- 250
Catalog #
AvailableQty
Starting At
Name
Company Name
Description
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
Analyte Specific Reagent. Analytical and performance characteristics are not established.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
The NovocastraTM Peroxidase Block RE7101 is intended for use in the peroxidase based immunohistochemical (IHC) staining procedures described in the Instructions for Use of the NovocastraTM Peroxidase Detection Systems RE7110-K/RE7120-K, NovocastraTM Concentrated Peroxidase Detection System RE7130-K and NovoLinkTM Polymer Detection Systems RE7140-K/RE7150-K.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
The Novocastra™ Protein Block RE7102 is intended for use in immunohistochemical (IHC) staining procedure described in the Instructions for Use of the NovocastraTM Peroxidase Detection Systems RE7110-K/RE7120-K, NovocastraTM Concentrated Peroxidase Detection System RE7130-K and NovoLinkTM Polymer Detection Systems RE7140-K/RE7150-K.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
Novocastra™ Hematoxylin RE7107 is intended for use in immunohistochemical (IHC) staining procedures such as those described in the Instructions for Use of the Novocastra™ Peroxidase Detection Systems RE7110-K/RE7120-K, Novocastra™ Concentrated Peroxidase Detection System RE7130-K and Novolink™ Polymer Detection Systems RE7140-K/RE7150-K.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
The Novocastra™ Epitope Retrieval Solutions RE7113, RE7114, RE7116 and RE7119 are intended for Heat Induced Epitope Retrieval on formalin-fixed, paraffin-embedded tissue sections as part of an immunohistochemical procedure.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
The Novocastra™ Epitope Retrieval Solutions RE7113, RE7114, RE7116 and RE7119 are intended for Heat Induced Epitope Retrieval on formalin-fixed, paraffin-embedded tissue sections as part of an immunohistochemical procedure.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
The Novocastra™ Epitope Retrieval Solutions RE7113, RE7114, RE7116 and RE7119 are intended for Heat Induced Epitope Retrieval on formalin-fixed, paraffin-embedded tissue sections as part of an immunohistochemical procedure.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
Novocastra™ IHC Diluent RE7133 is intended for use as a diluent for Novocastra™ primary antibodies, Novocastra™ ConcentratedBiotinylated Secondary Antibody RE7108 and Novocastra™ Concentrated Streptavidin-HRP RE7109 in immunohistochemical (IHC) procedures.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NovocastraTM Enzyme Proteinase K (IHC) is intended for the enzymatic pretreatment of formalin-fixed, paraffin-embedded tissue sections prior to incubation with a primary antibody in an immunohistochemical (IHC) procedure.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
Analyte Specific Reagnet. Analytical and performance characteristics are not established.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
Analyte Specific Reagent. Analytical and performance characteristics are not established.